Elanco (ELAN) fundamentals: P/E, valuation, undervalued?
Elanco · Health Care · ref. ETF XLV · price $22.41
In short — Elanco trades at —× earnings (P/E), 17.4× forward, with a net margin of -4.0 % and revenue growth of +10 %. Read: Not (yet) profitable (valued on growth, not earnings).
Is Elanco stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$22.41+10.8% over range
Oct 14, 25low $19.8 · high $26.84Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 6 analysts
Valuation : Not (yet) profitable — valued on growth, not earnings
Valuation
—
P/E (price/earnings)
17.4
Forward P/E
—
PEG
1.7
Price/book (P/B)
$11.2B
Market cap
-0.41
EPS
Profitability & growth
-4.0 %
Net margin
+10 %
Revenue growth
+441 %
Earnings growth
$4.2B
Total debt
Elanco income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $4.4B | $-74M | -1.7 % |
| 2023 | $4.4B | $-1.2B | -27.9 % |
| 2024 | $4.4B | $338M | 7.6 % |
| 2025 | $4.7B | $-232M | -4.9 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Elanco's P/E and is the stock undervalued? What's a good P/E?
Elanco's P/E is — (forward 17.4). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Not (yet) profitable".
Is Elanco profitable?
Elanco has a net margin of -4.0 % (EPS -0.41). The company is not (yet) profitable.
Is ELAN stock expensive?
Our read: "Not (yet) profitable" — valued on growth, not earnings. Cross-check with growth and sector.
💬 A question about Elanco? The JPI assistant answers using our backtest data.